Biofil Chemicals (India) Buy Hold or Sell Recommendation
BIOFILCHEM | 62.15 2.39 4.00% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Biofil Chemicals Pharmaceuticals is 'Strong Sell'. Macroaxis provides Biofil Chemicals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIOFILCHEM positions.
Check out Biofil Chemicals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Biofil and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Biofil |
Execute Biofil Chemicals Buy or Sell Advice
The Biofil recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biofil Chemicals Pharmaceuticals. Macroaxis does not own or have any residual interests in Biofil Chemicals Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biofil Chemicals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Biofil Chemicals Trading Alerts and Improvement Suggestions
Biofil Chemicals Pha had very high historical volatility over the last 90 days | |
Biofil Chemicals Pha is unlikely to experience financial distress in the next 2 years | |
About 60.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: Biofil Chem Standalone September 2024 Net Sales at Rs 2.41 crore, down 86.11 percent Y-o-Y - Moneycontrol |
Biofil Chemicals Returns Distribution Density
The distribution of Biofil Chemicals' historical returns is an attempt to chart the uncertainty of Biofil Chemicals' future price movements. The chart of the probability distribution of Biofil Chemicals daily returns describes the distribution of returns around its average expected value. We use Biofil Chemicals Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biofil Chemicals returns is essential to provide solid investment advice for Biofil Chemicals.
Mean Return | -0.11 | Value At Risk | -4.53 | Potential Upside | 5.41 | Standard Deviation | 4.10 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biofil Chemicals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Biofil Chemicals Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (5.0M) | (26.5M) | 30.5M | 797K | (13.4M) | (12.7M) | |
Change In Cash | 1.2M | 1.8M | (3.0M) | (1.1M) | 22.5M | 23.6M | |
Free Cash Flow | 8.4M | 5.4M | (2.9M) | (1.2M) | 23.7M | 24.9M | |
Depreciation | 4.3M | 4.2M | 4.3M | 4.3M | 4.0M | 3.2M | |
Other Non Cash Items | 146K | (6.1M) | (2.7M) | (2.9M) | 2.3M | 2.5M | |
Capital Expenditures | 2.1M | 5.7M | 699K | 106K | 229K | 217.6K | |
Net Income | 14.6M | 19.2M | 10.1M | 7.9M | 7.1M | 9.3M | |
End Period Cash Flow | 2.6M | 4.4M | 1.4M | 376K | 22.8M | 24.0M | |
Net Borrowings | 788K | (4.5M) | (7.6M) | 348K | 313.2K | 328.9K | |
Change To Netincome | 1.6M | 1.5M | 725K | 508K | 584.2K | 898.9K | |
Investments | (2.1M) | (961K) | (699K) | (106K) | (229K) | (240.5K) |
Biofil Chemicals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biofil Chemicals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biofil Chemicals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biofil stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | -0.5 | |
σ | Overall volatility | 4.21 | |
Ir | Information ratio | -0.06 |
Biofil Chemicals Volatility Alert
Biofil Chemicals Pharmaceuticals exhibits very low volatility with skewness of 1.62 and kurtosis of 5.56. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biofil Chemicals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biofil Chemicals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Biofil Chemicals Fundamentals Vs Peers
Comparing Biofil Chemicals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biofil Chemicals' direct or indirect competition across all of the common fundamentals between Biofil Chemicals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biofil Chemicals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biofil Chemicals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Biofil Chemicals by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Biofil Chemicals to competition |
Fundamentals | Biofil Chemicals | Peer Average |
Return On Equity | 0.04 | -0.31 |
Return On Asset | 0.0144 | -0.14 |
Profit Margin | 0.01 % | (1.27) % |
Operating Margin | 0.03 % | (5.51) % |
Current Valuation | 973.08 M | 16.62 B |
Shares Outstanding | 16.27 M | 571.82 M |
Shares Owned By Insiders | 59.85 % | 10.09 % |
Price To Book | 5.29 X | 9.51 X |
Price To Sales | 2.13 X | 11.42 X |
Revenue | 400.35 M | 9.43 B |
Gross Profit | 25.63 M | 27.38 B |
EBITDA | 13.06 M | 3.9 B |
Net Income | 7.09 M | 570.98 M |
Cash And Equivalents | 260 K | 2.7 B |
Total Debt | 4.39 M | 5.32 B |
Book Value Per Share | 11.19 X | 1.93 K |
Cash Flow From Operations | 23.94 M | 971.22 M |
Earnings Per Share | 0.39 X | 3.12 X |
Number Of Employees | 26 | 18.84 K |
Beta | 2.66 | -0.15 |
Market Capitalization | 979.42 M | 19.03 B |
Total Asset | 470.83 M | 29.47 B |
Retained Earnings | (318.26 M) | 9.33 B |
Working Capital | 98.83 M | 1.48 B |
Net Asset | 470.83 M |
Biofil Chemicals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biofil . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Biofil Chemicals Buy or Sell Advice
When is the right time to buy or sell Biofil Chemicals Pharmaceuticals? Buying financial instruments such as Biofil Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Biofil Chemicals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marijuana Thematic Idea Now
Marijuana
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
View All Next | Launch |
Other Information on Investing in Biofil Stock
Biofil Chemicals financial ratios help investors to determine whether Biofil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biofil with respect to the benefits of owning Biofil Chemicals security.